Xtant Medical Holdings (XTNT) Research & Development (2013 - 2025)
Xtant Medical Holdings (XTNT) reported Research & Development of $634000.0 for Q3 2025, down 9.56% year-over-year from $701000.0 in Q3 2024, and up 12.01% on a QoQ basis from $566000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) has 13 years of Research & Development data on file, last reported at $634000.0 in Q3 2025.
- Quarterly Research & Development fell 9.56% year-over-year to $634000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.2 million (down 8.11% YoY) and the FY2024 annual result came in at $2.4 million, up 78.52% from the prior year.
- Research & Development advanced to $634000.0 in Q3 2025 per XTNT's latest filing, from $566000.0 in the prior quarter.
- Across five years, Research & Development topped out at $701000.0 in Q3 2024 and bottomed at $151000.0 in Q4 2021.
- The 5-year median for Research & Development is $262000.0 (2021), against an average of $376315.8.
- The widest annual swing landed in 2023, when Research & Development retreated 25.31%; it then jumped 253.33% in 2024.
- Tracing XTNT's Research & Development over 5 years: stood at $151000.0 in 2021, then surged by 53.64% to $232000.0 in 2022, then soared by 112.07% to $492000.0 in 2023, then advanced by 6.1% to $522000.0 in 2024, then advanced by 21.46% to $634000.0 in 2025.
- Per Business Quant, the three latest XTNT Research & Development figures stand at $634000.0 (Q3 2025), $566000.0 (Q2 2025), and $443000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 566,000.00 |
| Mar 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 701,000.00 |
| Jun 30, 2024 | 636,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 492,000.00 |
| Sep 30, 2023 | 490,000.00 |
| Jun 30, 2023 | 180,000.00 |
| Mar 31, 2023 | 174,000.00 |
| Dec 31, 2022 | 232,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 213,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 262,000.00 |
| Jun 30, 2021 | 243,000.00 |
| Mar 31, 2021 | 214,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Sep 30, 2020 | 176,000.00 |
| Jun 30, 2020 | 111,000.00 |
| Mar 31, 2020 | 245,000.00 |
| Dec 31, 2019 | 257,000.00 |
| Sep 30, 2019 | 203,000.00 |
| Jun 30, 2019 | 210,000.00 |
| Mar 31, 2019 | 262,000.00 |
| Dec 31, 2018 | 523,000.00 |
| Sep 30, 2018 | 347,000.00 |
| Jun 30, 2018 | 418,000.00 |
| Mar 31, 2018 | 414,000.00 |
| Dec 31, 2017 | 598,000.00 |
| Sep 30, 2017 | 504,000.00 |
| Jun 30, 2017 | 640,000.00 |
| Mar 31, 2017 | 699,000.00 |
| Dec 31, 2016 | 798,198.00 |
| Sep 30, 2016 | 928,930.00 |
| Jun 30, 2016 | 783,897.00 |
| Mar 31, 2016 | 899,575.00 |
| Dec 31, 2015 | 1.03 Mn |
| Sep 30, 2015 | 794,464.00 |
| Jun 30, 2015 | 291,171.00 |
| Mar 31, 2015 | 433,561.00 |
| Dec 31, 2014 | 487,907.00 |
| Sep 30, 2014 | 378,252.00 |
| Jun 30, 2014 | 322,277.00 |
| Mar 31, 2014 | 254,583.00 |
| Jun 30, 2013 | 169,755.00 |
| Mar 31, 2013 | 285,080.00 |